BioGaia AB

BGLA

Company Profile

  • Business description

    BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions; Asia Pacific, Europe, the Middle East, Africa, and the Americas.

  • Contact

    Kungsbroplan 3A
    StockholmSE-112 27
    SWE

    T: +46 855529300

    E: [email protected]

    https://www.biogaia.se

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    238

Stocks News & Analysis

stocks

Netflix and Warner Bros. Discovery: Surprisingly high merger price alters shareholder value for both

Our view on the blockbuster merger.
stocks

The trillion-dollar club: Are these mega-sized stocks still buys?

The biggest stocks got bigger this year, breaking multi-trillion-dollar milestones.
stocks

New pricing model for embattled ASX tech leader

Investor day shows off potentially disruptive pricing model.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,926.1019.300.22%
CAC 408,114.747.29-0.09%
DAX 4024,028.14146.110.61%
Dow JONES (US)47,954.99104.050.22%
FTSE 1009,667.0143.86-0.45%
HKSE26,085.08149.180.58%
NASDAQ23,578.1372.990.31%
Nikkei 22550,491.87536.55-1.05%
NZX 50 Index13,483.9931.63-0.23%
S&P 5006,870.4013.280.19%
S&P/ASX 2008,634.6020.500.24%
SSE Composite Index3,902.8127.010.70%

Market Movers